Clearmind Medicine Inc (CMND) - News Archive

In a noteworthy development within the biotech landscape, Clearmind Medicine Inc. (Nasdaq: CMND), a Vancouver-based company dedicated to pioneering novel therapeutics for under-treated health issues, has received unanim...

In a significant advancement for the future of Alcohol Use Disorder (AUD) treatment, Clearmind Medicine Inc. (Nasdaq: CMND, FSE: CWY0) announced it has received final approval to expand its innovative Phase 1/2a clinica...

In a significant development for the biotechnology sector, Clearmind Medicine Inc. (NASDAQ: CMND) has received a notice of allowance for a patent covering its innovative approach to mitigating binge behavior, contributi...

Clearmind Medicine: Pioneering Psychedelic-Derived Therapeutics for Alcohol Use Disorder and Obesity In the rapidly evolving field of pharmaceutical development, Clearmind Medicine Inc. is standing out as a trailblazer...

In an ambitious move to enhance the effectiveness of its psychedelic-based treatments, Clearmind Medicine Inc. has announced plans to evaluate the intranasal delivery of its unique psychedelic drug combinations. This st...

Pioneering Psychedelic Frontiers: Clearmind Medicine s Strategic Leap in Alcohol Use Disorder Treatment Trials Clearmind Medicine Inc. has taken significant strides toward transforming the landscape of alcohol use disor...

Clearmind Medicine: Pioneering Ibogaine Combination Therapy Amid Competitive Market Challenges Clearmind Medicine is a beacon of innovation in the biopharmaceutical industry, yet it faces significant financial headwinds...

Pioneering the Frontier of PTSD Treatment: Clearmind Medicine and Yissum File International Patent for Revolutionary Psychedelic Compounds Innovative compounds designed to address critical unmet needs in PTSD treatmentI...

Vancouver, Canada, August 29, 2024 In an era of scientific advancement and relentless pursuit of innovative solutions for hitherto inadequately addressed health maladies, Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CW...

Clearmind Medicine Secures U.S. Patent for Binge Behavior Treatment Amid Financial Challenges Vancouver, Canada August 21, 2024 Clearmind Medicine Inc. (Nasdaq: CMND, FSE: CWY0), a clinical-stage biotech company pioneer...

In a world grappling with a mental health crisis, innovative solutions are desperately needed. The psychedelic renaissance is upon us, and companies like Clearmind Medicine Inc. (Nasdaq: CMND) are leading the way in dev...

: The metabolic disorder obesity continues to pose significant health challenges worldwide, underscoring the urgent need for innovative therapeutic solutions. Recently, a study spearheaded by Clearmind Medicine Inc., a...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0), a clinical-stage biotech company focused on the discovery and development of novel psychedelic-derived therapeutics, has recently made significant advancements in its...

Clearmind Medicine Expands Global Reach with Partnership for Alcohol Substitute Beverage, Secures Exclusive Rights for PTSD Treatment, and Announces Licensing Agreement for Mental DisordersVancouver, Canada - Clearmind...

Innovative Treatment for Alcoholism: Clearmind Medicine s IND Approval for MEAI-Based CMND-100 Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) a Vancouver-based clinical-stage biotech company is revolutionizing the...

Clearmind Medicine Secured Exclusive Global Rights to Innovative Psychedelic Compounds for PTSD TreatmentVancouver-based biotech company, Clearmind Medicine Inc. (Nasdaq: CMND), recently made an exciting announcement re...

Clearmind Medicine Inc., a clinical-stage biotech company, has made significant strides in revolutionizing the non-alcoholic beverages market with its groundbreaking psychedelic-based drink. Alongside this achievement,...

Clearmind Medicine Inc., a Vancouver-based clinical-stage biotech company, has recently announced a significant development in the field of psychedelic-derived therapeutics to address the under-treated health issue of p...

Clearmind Medicine Partners with Hebrew University to Develop Generation 3.0 Psychedelic Compounds for Mental Disorders TreatmentTel Aviv, Israel / Vancouver, Canada, April 17, 2024 - Clearmind Medicine Inc. (Nasdaq: CM...

Clearmind Medicine Inc., a clinical-stage biotech company, has recently achieved significant milestones in its pursuit of using novel psychedelic-derived therapeutics to address major health challenges. This article exp...